Health knowledge made personal
Join this community!
› Share page:
Go
Search posts:

Drug Companies & Doctors: A Story of Corruption

Posted Jan 07 2009 4:42pm
Ezra Klein directs us to a NY Times Book Review piece on doctors, research, evidence-based medicine and drug companies:
Conflicts of interest affect more than research. They also directly shape the way medicine is practiced, through their influence on practice guidelines issued by professional and governmental bodies, and through their effects on FDA decisions. A few examples: in a survey of two hundred expert panels that issued practice guidelines, one third of the panel members acknowledged that they had some financial interest in the drugs they considered. In 2004, after the National Cholesterol Education Program called for sharply lowering the desired levels of "bad" cholesterol, it was revealed that eight of nine members of the panel writing the recommendations had financial ties to the makers of cholesterol-lowering drugs. Of the 170 contributors to the most recent edition of the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders (DSM), ninety-five had financial ties to drug companies, including all of the contributors to the sections on mood disorders and schizophrenia. Perhaps most important, many members of the standing committees of experts that advise the FDA on drug approvals also have financial ties to the pharmaceutical industry.
Combine this with my recent posts about publication bias and researcher allegiance effects and it's enough to make a cynic wonder if they've mustered sufficient skepticism. Oy.
Post a comment
Write a comment:

Related Searches